HCG11 and breast carcinoma: A study published in 2016 (Liu et al., 2016) looking for lncRNAs as prognostic markers for human breast cancer has associated the poor overall survival (OS) with the expression levels (upregulation) of four lncRNAs, including NORAD (LINC00657) and HCG11.